326 related articles for article (PubMed ID: 23255114)
21. SET and PARP1 remove DEK from chromatin to permit access by the transcription machinery.
Gamble MJ; Fisher RP
Nat Struct Mol Biol; 2007 Jun; 14(6):548-55. PubMed ID: 17529993
[TBL] [Abstract][Full Text] [Related]
22. DEK regulates hematopoietic stem engraftment and progenitor cell proliferation.
Broxmeyer HE; Kappes F; Mor-Vaknin N; Legendre M; Kinzfogl J; Cooper S; Hangoc G; Markovitz DM
Stem Cells Dev; 2012 Jun; 21(9):1449-54. PubMed ID: 21943234
[TBL] [Abstract][Full Text] [Related]
23. Imaging-based study demonstrates how the DEK nanoscale distribution differentially correlates with epigenetic marks in a breast cancer model.
Pierzynska-Mach A; Cainero I; Oneto M; Ferrando-May E; Lanzanò L; Diaspro A
Sci Rep; 2023 Aug; 13(1):12749. PubMed ID: 37550322
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.
Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z
PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858
[TBL] [Abstract][Full Text] [Related]
25. A role for intracellular and extracellular DEK in regulating hematopoiesis.
Capitano ML; Broxmeyer HE
Curr Opin Hematol; 2017 Jul; 24(4):300-306. PubMed ID: 28306668
[TBL] [Abstract][Full Text] [Related]
26. Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status.
Wang DM; Liu L; Fan L; Zou ZJ; Zhang LN; Yang S; Li JY; Xu W
Cancer Biol Ther; 2012 Dec; 13(14):1522-8. PubMed ID: 23052131
[TBL] [Abstract][Full Text] [Related]
27. DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies.
Pierzynska-Mach A; Czada C; Vogel C; Gwosch E; Osswald X; Bartoschek D; Diaspro A; Kappes F; Ferrando-May E
J Cell Sci; 2023 Dec; 136(23):. PubMed ID: 37997922
[TBL] [Abstract][Full Text] [Related]
28. All hands on DEK.
Bodine DM
J Clin Invest; 2019 May; 129(6):2205-2206. PubMed ID: 31107244
[TBL] [Abstract][Full Text] [Related]
29. The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.
Deutzmann A; Ganz M; Schönenberger F; Vervoorts J; Kappes F; Ferrando-May E
Oncogene; 2015 Aug; 34(32):4270-7. PubMed ID: 25347734
[TBL] [Abstract][Full Text] [Related]
30. DEK proto-oncogene expression interferes with the normal epithelial differentiation program.
Wise-Draper TM; Morreale RJ; Morris TA; Mintz-Cole RA; Hoskins EE; Balsitis SJ; Husseinzadeh N; Witte DP; Wikenheiser-Brokamp KA; Lambert PF; Wells SI
Am J Pathol; 2009 Jan; 174(1):71-81. PubMed ID: 19036808
[TBL] [Abstract][Full Text] [Related]
31. Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.
Datta A; Adelson ME; Mogilevkin Y; Mordechai E; Sidi AA; Trama JP
BMC Cancer; 2011 Jun; 11():234. PubMed ID: 21663673
[TBL] [Abstract][Full Text] [Related]
32. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival.
Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K
Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857
[TBL] [Abstract][Full Text] [Related]
33. Concise review: role of DEK in stem/progenitor cell biology.
Broxmeyer HE; Mor-Vaknin N; Kappes F; Legendre M; Saha AK; Ou X; O'Leary H; Capitano M; Cooper S; Markovitz DM
Stem Cells; 2013 Aug; 31(8):1447-53. PubMed ID: 23733396
[TBL] [Abstract][Full Text] [Related]
34. Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene.
Sammons M; Wan SS; Vogel NL; Mientjes EJ; Grosveld G; Ashburner BP
J Biol Chem; 2006 Sep; 281(37):26802-12. PubMed ID: 16829531
[TBL] [Abstract][Full Text] [Related]
35. IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival.
Adams AK; Bolanos LC; Dexheimer PJ; Karns RA; Aronow BJ; Komurov K; Jegga AG; Casper KA; Patil YJ; Wilson KM; Starczynowski DT; Wells SI
Oncotarget; 2015 Dec; 6(41):43395-407. PubMed ID: 26527316
[TBL] [Abstract][Full Text] [Related]
36. The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia.
Wilcher KE; Page ERH; Privette Vinnedge LM
Exp Hematol; 2023 Jul; 123():18-27. PubMed ID: 37172756
[TBL] [Abstract][Full Text] [Related]
37. The distribution of the DEK protein in mammalian chromatin.
Hu HG; Scholten I; Gruss C; Knippers R
Biochem Biophys Res Commun; 2007 Jul; 358(4):1008-14. PubMed ID: 17524367
[TBL] [Abstract][Full Text] [Related]
38. The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin-specific manner.
Alexiadis V; Waldmann T; Andersen J; Mann M; Knippers R; Gruss C
Genes Dev; 2000 Jun; 14(11):1308-12. PubMed ID: 10837023
[TBL] [Abstract][Full Text] [Related]
39. DEK oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.
Kappes F; Damoc C; Knippers R; Przybylski M; Pinna LA; Gruss C
Mol Cell Biol; 2004 Jul; 24(13):6011-20. PubMed ID: 15199154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
